News
Exclusive-ASML CEO sees tight supply in booming chip market as AI demand soars
2+ hour, 27+ min ago (675+ words) ANTWERP, Belgium, May 20 (Reuters) " The booming global semiconductor market will be "tense" with tight supply for the foreseeable future, the head of chip-making machine giant ASML told Reuters, with demand from AI, satellites and robots outpacing what the industry can…...
ASML says first chips made with High-NA machines to arrive in months
1+ day, 4+ hour ago (402+ words) By Toby Sterling and Nathan Vifflin ANTWERP, May 19 (Reuters) " ASML expects the first chips made with its next-generation High-NA EUV machines to be delivered within months, Chief Executive Christophe Fouquet said on Tuesday, as the "Dutch company addresses concerns about…...
US software stocks rebound, seeking to loosen AI's grip
1+ day, 8+ hour ago (376+ words) May 19 (Reuters) " Shares of several U. S. software stocks gained on Tuesday, as the industry attempts a comeback after being battered for much of the year on fears of disruption "from artificial intelligence. The beleaguered sector's rebound coincided with a slide in…...
Roche, Medicines Patent Pool sign deal to expand access to influenza drug
2+ day, 1+ hour ago (303+ words) May 18 (Reuters) " Roche and the Medicines Patent Pool have signed a licensing agreement to expand access to the Swiss drugmaker's flu drug, Xofluza, in low- "and middle-income countries, the organizations said on Monday, aiming "to boost supply during seasonal outbreaks…...
Next Era Energy strikes $66. 8 billion deal for Dominion in bets on AI power demand
2+ day, 8+ hour ago (254+ words) By Vallari Srivastava May 18 (Reuters) - Next Era Energy will buy Dominion Energy in an all-stock transaction valued at about $66. 8 billion, creating the world's largest regulated electric utility by market value, as U. S. utilities race to meet surging. .....
Bio Marin’s genetic disease therapy shows mixed results in late-stage study
2+ day, 8+ hour ago (44+ words) By Sneha S K and Kunal Das May 18 (Reuters) - Bio Marin Pharmaceutical said on Monday its experimental treatment for a rare genetic condition met one of the two main goals "in a late-stage study. The company was testing its enzyme…...
Regeneron drops after skin cancer treatment misses late-stage trial goal
2+ day, 10+ hour ago (321+ words) May 18 (Reuters) " Shares of Regeneron fell 11. 6% premarket on Monday after the company's experimental treatment missed the main goal in a late-stage head-to-head "trial for patients with a type of skin cancer. Late "on Friday, the drugmaker said its fianlimab-cemiplimab combination…...
Equinix faces challenge to Cape Town data centres over environmental concerns
2+ day, 14+ hour ago (418+ words) LONDON, May 18 (Reuters) " A plan by U. S. -listed Equinix to build two data centres in Cape Town should not be approved without full disclosure of its water, power and environmental impact, a formal objection "lodged with city planners and seen by…...
As chip industry chases AI, U. S. national labs look to newcomers for supercomputers
2+ day, 14+ hour ago (462+ words) For more than a decade, the chips handling this secretive and demanding work came from mainstream semiconductor firms like Nvidia or Advanced "Micro Devices. "The pressure we're feeling right now is on the computing front and also from the supply…...
China’s CXMT expects revenue to surge as memory chip demand soars
2+ day, 19+ hour ago (41+ words) By Che Pan and Laurie Chen BEIJING, May 18 (Reuters) - Changxin Memory Technologies (CXMT), China's top memory chipmaker, said on Sunday it expects first-half revenue to "reach 110 billion yuan to 120 billion yuan ($17. 62 billion), according to a ren. .....